StockData
Cingulate Inc. logo

Cingulate Inc. (CING) stock

CINGNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as CINGW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$4.64+0.08 (+1.75%)

Close on Nov 11, 2026Market cap $67.47MP/E –Yield –

Cingulate statistics

62 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Nov 12, 2026 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Nov 11, 2026

Valuation ratiosIndustry

Market Cap
$67.47M
$282.97M
Enterprise Value
$39.07M
$154.96M
PB Ratio
2.88
2.17
P/TBV Ratio
2.88
2.39

Share statisticsIndustry

Shares Change (QoQ)
16.7%
0.51%
Float
10M
49M
Shares Held by Insiders
28.4%
11.6%
Shares Held by Institutions
13.4%
56.4%

Short sellingIndustry

Short Interest
1M
–
Short Interest Change
2.03%
-0.76%
Days to Cover
7.52
5.16

Stock price statisticsIndustry

52-Week High
$11.89
–
52-Week Low
$3.16
–
20-Day Moving Average
$4.73
–
50-Day Moving Average
$4.88
–
200-Day Moving Average
$5.40
–
Average True Range (14)
$0.30
–
Price Change (1 Week)
1.75%
-0.50%
Price Change (1 Month)
-1.69%
-0.33%
Price Change (3 Months)
-7.01%
-17.2%
Price Change (6 Months)
-5.69%
-20.1%
Price Change (YTD)
6.91%
-20.1%
Price Change (1 Year)
27.8%
-19.3%
Price Change (3 Years)
-93.9%
-23.4%
Average Volume (10 Days)
115,744
–
Average Volume (20 Days)
137,333
–
Average Volume (90 Days)
142,388
–
Relative Volume
0.95
0.73
Relative Strength Index (14)
47.0
47.6
Volatility (1 Year)
87.6%
80.2%
Beta (5 Years)
2.08
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-198.7%
-51.3%
Return on Assets (ROA)
-123.8%
-40.3%
Return on Capital Employed (ROCE)
-102.0%
-37.7%

Financial positionIndustry

Current Ratio
3.50
3.30
Quick Ratio
3.29
2.37

EfficiencyIndustry

Profits Per Employee
-$57.59K
-$680.86K
Employee Count
500
75
WACC
15.3%
10.1%

Income statement (TTM)Industry

Operating Income
-$24.92M
-$20.20M
Pretax Income
-$28.80M
-$13.50M
Net Income
-$28.80M
-$21.57M
EBITDA
-$24.92M
-$16.36M
EPS (Diluted)
-$3.68
-$0.77

Balance sheetIndustry

Net Cash (Debt)
$28.40M
$16.31M
Net Cash Per Share
$1.95
$0.70
Equity (Book Value)
$23.47M
$53.12M
Book Value Per Share
$1.61
$1.49
Tangible Book Value
$23.47M
$26.11M
Working Capital
$21.58M
$77.59M

Cash flow (TTM)Industry

Operating Cash Flow
-$20.65M
-$12.07M
Capital Expenditures
-$284.48K
-$939.00K
Free Cash Flow
-$20.94M
-$18.37M
FCF Per Share
-$1.44
-$0.42

Dividends and yieldsIndustry

Earnings Yield
-42.7%
-19.8%
FCF Yield
-31.0%
-8.81%
Buyback Yield
-52.0%
-0.69%
Shareholder Yield
-52.0%
0.00%

Scores and fair valueIndustry

Altman Z-Score
-3.73
0.28
Piotroski F-Score
3
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.

PeriodCINGS&P 500DifferenceCING per yearS&P 500 per year
1 month-5.1%-2.4%−2.7 pts
3 months-10.8%-1.2%−9.6 pts
Year to date+6.9%+12.3%−5.4 pts
1 year+26.4%+12.4%+14.0 pts
3 years-93.9%+78.8%−172.7 pts-60.6%+21.4%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M CING shares were sold short on Oct 30, 2026, up 2.0% from the previous report. At recent volumes it would take 7.5 days to buy them back. Over the last 20 sessions, 39.1% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20261,037,583+2.0%138,0097.5
Oct 15, 20261,016,929-1.4%86,17411.8
Sep 30, 20261,031,388-11.9%98,27810.5
Sep 15, 20261,170,285+10.9%86,54813.5
Aug 31, 20261,055,174-12.3%161,2006.5
Aug 14, 20261,203,157-23.4%154,2527.8
Jul 31, 20261,569,743-6.5%156,73410.0
Jul 15, 20261,678,218+22.0%348,8264.8
Jun 30, 20261,375,106-21.9%381,6383.6
Jun 15, 20261,761,155-10.1%923,1941.9
May 29, 20261,959,020+24.2%639,7443.1
May 15, 20261,577,160+5.4%442,5573.6

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?